FMR LLC
Institutional investor · Portfolio as of Q3 2020
Top Holdings3,756 positions
AMAZON.COM INC | 15.9M | $50B | 5.1% | — | — | — | Decreased 0 |
MICROSOFT CORP | 236.7M | $49.8B | 5.0% | — | — | — | Decreased 0 |
APPLE INC | 346.7M | $40.2B | 4.1% | — | — | — | Increased 94 |
META PLATFORMS INC | 124M | $32.5B | 3.3% | — | — | — | Decreased 0 |
NVIDIA CORP | 44.7M | $24.2B | 2.4% | — | — | — | Decreased 0 |
SALESFORCE.COM INC | 82.4M | $20.7B | 2.1% | — | — | — | Decreased 0 |
ALPHABET INC-CL A | 12.6M | $18.5B | 1.9% | — | — | — | Increased 51 |
UNITEDHEALTH GROUP INC | 52.3M | $16.3B | 1.6% | — | — | — | Decreased 0 |
ADOBE INC | 30.3M | $14.8B | 1.5% | — | — | — | Decreased 0 |
VISA INC-CLASS A SHARES | 72.8M | $14.5B | 1.5% | — | — | — | Decreased 0 |
MASTERCARD INC - A | 35.7M | $12.1B | 1.2% | — | — | — | Decreased 0 |
ALPHABET INC-CL C | 7.7M | $11.3B | 1.1% | — | — | — | Decreased 0 |
ALIBABA GROUP HLDG LTD | 37.7M | $11.1B | 1.1% | — | — | — | Increased 63 |
NETFLIX INC | 20.6M | $10.3B | 1.0% | — | — | — | Decreased 0 |
BERKSHIRE HATHAWAY INC-CL A | 31,061 | $9.9B | 1.0% | — | — | — | Increased 50 |
PAYPAL HLDGS INC | 47.5M | $9.4B | 0.9% | — | — | — | Increased 45 |
REGENERON PHARMACEUTICALS | 12.7M | $7.1B | 0.7% | — | — | — | Increased 46 |
SHOPIFY INC - CLASS A | 6.8M | $7B | 0.7% | — | — | — | Decreased 0 |
TESLA INC | 15.6M | $6.7B | 0.7% | — | — | — | Increased 73 |
QUALCOMM INC | 55.1M | $6.5B | 0.7% | — | — | — | Increased 48 |
FMR LLC manages $989.3B across 3756 positions as of Q3 2020. Top holdings: AMZN (5.1%), MSFT (5.0%), AAPL (4.1%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.
Active quarter - 289 new positions, 490 exits, 1378 increased. Top move: AAPL (INCREASED, conviction 94). Portfolio: $989.3B across 3756 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR